Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Aeterna Zentaris doubles down on macimorelin PhIII, and loses
Aeterna Zentaris doubles down on macimorelin PhIII, and loses
Aeterna Zentaris doubles down on macimorelin PhIII, and loses
Submitted by
admin
on January 5, 2017 - 9:08am
Source:
Endpoints
News Tags:
Aeterna Zentaris
macimorelin
clinical trials
growth hormone deficiency
Headline:
Aeterna Zentaris doubles down on macimorelin PhIII, and loses
Do Not Allow Advertisers to Use My Personal information
